Business Wire

Hyperice Introduces Hypervolt Go 2 as Everyday Wellness Essential for All

Share

Hyperice, a global high-performance wellness brand, today introduced a new and improved version of its original, award-winning handheld massage gun, the Hypervolt Go. Leveling up and standing on its own within the percussive massage category, the newly redesigned, lightweight and versatile Hypervolt Go 2 is the most sophisticated portable percussion massager to hit the wellness market and is built to increase people’s range of motion with just a five minute treatment each day1.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220404005376/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Hyperice Introduces Hypervolt Go 2 as Everyday Wellness Essential for All (Photo: Business Wire)

The Hypervolt Go 2 adds to the company’s range of powerful percussion devices including the recently launched Hypervolt 2 and Hypervolt 2 Pro, all of which help everyday users and pro athletes alike massage away stress and muscle tension from the palm of their hand.

“For over 10 years, Hyperice has been relentlessly focused on developing innovative products to help people across the globe move and live better. The new Hypervolt Go 2 offers a unique combination of performance and portability for the wellness-minded consumer,” said Jim Huether, CEO of Hyperice. “Designed for the everyday go-getter, the Hypervolt Go 2 is a wellness essential - perfect for everyone who is moving at home or on the road and wants to be at their best everyday.”

“The Hypervolt Go 2 is the result of our 'design first’ approach to creating a product that looks as good as it feels. We wanted to design a product that people would want to take and use everywhere they go,” said Anthony Katz, Founder and President of Hyperice. “With this newest addition to the Hypervolt family, the Hypervolt Go 2 offers more choice, to more people, in more places than ever before.”

WELLNESS THAT MOVES WITH YOU

The new Hypervolt Go 2 has a sophisticated design that features minimalistic looks with an arctic-grey finish and feels great in your hand and on your body. It is built to last, with high-quality materials and intuitive ergonomics. The Hypervolt Go 2 is designed to move conveniently wherever users are headed and includes features such as:

  • Patented QuietGlide® technology for near silent operation
  • Improved airflow and ventilation
  • New LED speed sensors and back button control
  • New ergonomic handle
  • Battery level LED band
  • Three speeds of powerful percussion

Go behind the design of the Hypervolt Go 2.

Katz continued: “Our mission from the beginning, was to put a percussion device in as many hands as possible. To do that, we need to continue to design products that are accessible to the widest possible audience of users. We also know, with the world opening back up, people are constantly on the move, and space can oftentimes be limited, so the smaller you can make the device, the more places you can take it, the more you can use it. Hypervolt Go 2 represents the next step towards achieving that goal.”

“My current phase of my career is about longevity and maintaining a competitive advantage,” said Kelly Slater, 11-time World Surf League champion and Hyperice Athlete-Investor. “To be my best when I’m competing, I have to also feel great no matter where I am, which is why I never leave home without the Hypervolt Go 2. It’s the ultimate in portability, it’s dead silent and it comes in clutch whether I’m preparing for a major event or just managing everyday aches.”

The Hypervolt Go 2 retails for $199 (£199; €229) and is now available in North America and other select regions. For more information, visit hyperice.com. To purchase, please visit country-specific sites: Canada, France, Germany, Italy, Portugal, Spain, UK and the United States.

To learn more about the Hypervolt Go 2, visit hyperice.com.

INTRODUCING: THE GO COLLECTIVE

To amplify the ethos of the Go line, Hyperice has assembled a diverse collection of individuals within #TeamHyperice who represent different industries and backgrounds who are pushing the boundaries of what it means to ‘go get it.’ The Go Collective seeks to make a movement out of movement across the many dimensions of fitness, fashion, lifestyle, sports, travel, longevity, wellness, art, family, and more. Through expansive storytelling and involvement in community initiatives and events, Hyperice hopes the Go Collective will inspire individuals everywhere to prioritize their daily wellness.

Meet the inaugural Go Collective members:

  • Robin Arzón, Head Instructor and VP of Fitness Programming at Peloton
  • Tony Finau, PGA TOUR Golfer
  • Adrianne Ho, Model and Founder of Sweat The Style & The Farmers Market Global
  • Joe Holder, Nike Master Trainer and Founder of The Ocho System™
  • Alix Klineman, Beach Volleyball Olympic Gold Medalist
  • Kelly Slater, Professional Surfer
  • Nigel Sylvester, Pro BMX Athlete and Content Creator
  • Raven B. Varona (Ravie B), Professional Photographer

“I’m proud to be a member of Hyperice’s new Go Collective because it represents a community for people who show up everyday for themselves and for others,” said Robin Arzón, Head Instructor and VP of Fitness Programming at Peloton. “I believe there is transformative power in movement and as a mom, wife and athlete, being able to be at my best in all dimensions of my life is what motivates me to ‘go get it’. Hyperice’s suite of products, and the Hypervolt Go 2 in particular, are my go-to wellness tools that help me be at my best each and every day.”

“I take my role as a husband and father of five even more seriously than my career as a pro golfer. There’s no doubt staying healthy is a huge part of my commitment to performance, but more importantly, it’s critical to me that I’m the best version of myself whenever I’m spending valuable time with my family,” said Tony Finau, PGA TOUR player and Hyperice investor. “The Hypervolt Go 2 goes with me everywhere – on the course during competition, training and recovery, and when I’m traveling between tournaments – to ensure that I can push to the limits of my full potential for years to come.”

“When it comes to feeling your best, a major part of that is making sure to move and to move effectively everyday, and recovery is a critical component of a holistic approach to an individual’s overall wellness,” said Joe Holder, Nike Master Trainer and Founder of The Ocho System™. “As someone who gets the opportunity to help so many people unlock their personal version of wellness, the Hypervolt Go 2 is an incredible tool for anyone to utilize to help ensure they can come back day after day - ready to be anything but average.”

To join the Go Collective community, follow Hyperice on social - instagram.com/hyperice and twitter.com/hyperice and sign up for emails on hyperice.com to unlock exclusive content, special offers, access to events and more. Learn more at: hyperice.com/newsroom/go-collective

About Hyperice

Hyperice is a technology-driven company with a giant mission, to help everyone on Earth move and live better. For more than a decade, Hyperice has led a global movement at the confluence of recovery and wellness, specializing in percussion (Hypervolt line), dynamic air compression (Normatec line), vibration (Vyper and Hypersphere lines), thermal technology (Venom line), mind technology (Core by Hyperice) and contrast therapy (Hyperice X). Now, as a holistic high-performance wellness brand, Hyperice is designed for all - from the most elite athletes, leagues and teams to consumers everywhere looking to unlock the best version of themselves to help them do what they love, more. Recognized as one of Fast Company’s Most Innovative Companies, Hyperice has applied its technology and know-how to industries including fitness, hospitality, healthcare, massage, physical therapy, sports performance and workplace wellness on a global scale. Hyperice’s transformative acquisitions of Normatec, RecoverX and Core have helped to accelerate its innovation agenda as it enters its next stage of global growth. For more information, visit the newly redesigned hyperice.com.

1 Journal of Sports Science & Medicine 2020

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contact:
Jack Taylor PR
Nadine Hachicho
hyperice@jacktaylorpr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r

Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr

Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release

The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p

Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 01:49:00 EET | Press release

Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive Officer, Lattice Semiconductor. The annual GSA Awards celebrate the accomplishments of the semiconductor indu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye